Sensitive HPV detection in oropharyngeal cancers.

Abstract:

BACKGROUND:Human papillomaviruses (HPV) are the aetiological agents of certain benign and malignant tumours of skin and mucosae; the most important of which is cervical cancer. Also, the incidence of ano-genital warts, HPV-anal cancer and oropharyngeal cancers are rising. To help ascertain a useful PCR detection protocol for oropharyngeal cancers, we directly compared three commonly used primer sets in detection of HPV from different clinical samples. METHODS:We compared PGMY09/11, MY09/11 and GP5+/6+ primers sets in PCRs of 34 clinically diagnosed samples of genital warts, cervical brushings (with associated histological diagnosis) and vulval biopsies. All negative samples were subsequently tested using the previously reported PGMY/GP PCR method and amplicons directly sequenced for confirmation and typing. An optimised PCR protocol was then compared to a line blot assay for detection of HPV in 15 oropharyngeal cancer samples. RESULTS:PGMY09/11 primers detected HPV presence in more cervical brushing (100%) and genital wart (92.9%) samples compared to MY09/11 (90% and 64.3%) and GP5+/6+ (80% and 64.3%) primer sets, respectively. From vulval biopsies, HPV detection rates were: MY09/11 (63.6%), GP5+/6+ (54.5%) and PGMY09/11 (54.5%). PGMY/GP nested PCR demonstrated that HPV was present, and direct sequencing confirmed genotypes. This nested PCR protocol showed detection of HPV in 10/15 (66.7%) of oropharyngeal cancer samples. CONCLUSIONS:PGMY09/11 primers are the preferred primer set among these three for primary PCR screening with different clinical samples. MY09/11 and GP5+/6+ may be used (particularly for cervical samples) but demonstrate lower detection rates. A nested PCR approach (i.e. a PGMY-GP system) may be required to confirm negativity or to detect low levels of HPV, undetectable using current primary PCR methods, as demonstrated using oropharyngeal cancer samples.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Winder DM,Ball SL,Vaughan K,Hanna N,Woo YL,Fränzer JT,Sterling JC,Stanley MA,Sudhoff H,Goon PK

doi

10.1186/1471-2407-9-440

subject

Has Abstract

pub_date

2009-12-15 00:00:00

pages

440

issn

1471-2407

pii

1471-2407-9-440

journal_volume

9

pub_type

杂志文章
  • Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores.

    abstract:BACKGROUND:The oncofetal protein insulin-like growth factor II mRNA binding protein 3 (IMP3) is an important factor for cell-migration and adhesion in malignancies. Recent studies have shown a remarkable overexpression of IMP3 in different human malignant neoplasms and also revealed it as an important prognostic marker...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-341

    authors: Ikenberg K,Fritzsche FR,Zuerrer-Haerdi U,Hofmann I,Hermanns T,Seifert H,Müntener M,Provenzano M,Sulser T,Behnke S,Gerhardt J,Mortezavi A,Wild P,Hofstädter F,Burger M,Moch H,Kristiansen G

    更新日期:2010-06-30 00:00:00

  • Impact of diabetes mellitus on epithelial ovarian cancer survival.

    abstract:BACKGROUND:Diabetes mellitus (DM) is associated with poorer outcomes in some cancers. Its effect on ovarian cancer is less clear. We consider the effect of DM on overall survival (OS) and progression free survival (PFS) in patients with epithelial ovarian cancer (EOC). METHODS:A retrospective cohort study of 215 patie...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5162-3

    authors: Akhavan S,Ghahghaei-Nezamabadi A,Modaresgilani M,Mousavi AS,Sepidarkish M,Tehranian A,Rezayof E

    更新日期:2018-12-12 00:00:00

  • Phase-specific and lifetime costs of cancer care in Ontario, Canada.

    abstract:BACKGROUND:Cancer is a major public health issue and represents a significant economic burden to health care systems worldwide. The objective of this analysis was to estimate phase-specific, 5-year and lifetime net costs for the 21 most prevalent cancer sites, and remaining tumour sites combined, in Ontario, Canada. M...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2835-7

    authors: de Oliveira C,Pataky R,Bremner KE,Rangrej J,Chan KK,Cheung WY,Hoch JS,Peacock S,Krahn MD

    更新日期:2016-10-18 00:00:00

  • If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

    abstract:BACKGROUND:Staging of B-cell non Hodgkin's lymphoma (NHL) routinely involves bone marrow (BM) examination by trephine biopsy (BM-TB). The evidence of disease in the BM-TB results in a clinical stage IV classification affecting therapeutic strategies for NHL patients. BM immunophenotyping by flow cytometry (FC) is also ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-644

    authors: Mancuso P,Calleri A,Antoniotti P,Quarna J,Pruneri G,Bertolini F

    更新日期:2010-11-24 00:00:00

  • Computed tomography Hounsfield units can predict breast cancer metastasis to axillary lymph nodes.

    abstract:BACKGROUND:Axillary lymph node (ALN) status is an important prognostic factor for breast cancer. We retrospectively used contrast-enhanced computed tomography (CE-CT) to evaluate the presence of ALN, metastasis based on size, shape, and contrasting effects. METHODS:Of 131 consecutive patients who underwent CE-CT follo...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-730

    authors: Urata M,Kijima Y,Hirata M,Shinden Y,Arima H,Nakajo A,Koriyama C,Arigami T,Uenosono Y,Okumura H,Maemura K,Ishigami S,Yoshinaka H,Natsugoe S

    更新日期:2014-09-30 00:00:00

  • The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.

    abstract:BACKGROUND:BCOR acts as a corepressor of BCL6, a potent oncogenic protein in cancers of the lymphoid lineage. We have found the recurrent somatic mutation of BCOR occurred in mature T-cell lymphoma (TCL). The role of BCOR mutation in lymphoid malignancies is unknown. METHODS:Lymphoma patient samples were analyzed to i...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-021-07806-8

    authors: Kang JH,Lee SH,Lee J,Choi M,Cho J,Kim SJ,Kim WS,Ko YH,Yoo HY

    更新日期:2021-01-19 00:00:00

  • Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer.

    abstract:BACKGROUND:Novel biomarkers and molecular monitoring tools hold potential to improve outcome for patients following resection of pancreatic ductal adenocarcinoma (PDAC). We hypothesized that the combined longitudinal analysis of mutated cell-free plasma KRAS (cfKRASmut) and CA 19-9 during adjuvant treatment and follow-...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07736-x

    authors: Hussung S,Akhoundova D,Hipp J,Follo M,Klar RFU,Philipp U,Scherer F,von Bubnoff N,Duyster J,Boerries M,Wittel U,Fritsch RM

    更新日期:2021-01-11 00:00:00

  • Defining the optimal dose of radiation in leukemic patients with extramedullary lesions.

    abstract:BACKGROUND:Analysis of the clinical response of extramedullary lesions in leukemic patients treated with radiation therapy (RT) and defining the optimal dose of radiation. METHODS:Forty-two extramedullary lesions found in 24 leukemic patients treated with RT were reviewed. The radiation was delivered usually 2 Gy/day,...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-428

    authors: Song JH,Son SH,Lee JH,Chung SM,Jang HS,Choi BO

    更新日期:2011-10-06 00:00:00

  • Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics.

    abstract:BACKGROUND:The purpose of our study was to investigate the immunohistochemical expression of TGF-beta1 and p27 in pancreatic adenocarcinomas and to compare the findings with the clinicopathological features and survival. We also aimed to evaluate the expression of TGF-beta1 and p27 in the context of other cell cycle an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-98

    authors: Culhaci N,Sagol O,Karademir S,Astarcioglu H,Astarcioglu I,Soyturk M,Oztop I,Obuz F

    更新日期:2005-08-08 00:00:00

  • Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report.

    abstract::Following publication of the original article [1], the authors reported that the incorrect Fig. 2A was published in the article. The recovery times required to achieve a normal neutrophil count was omitted. The corrected Fig. 2 is given below. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-019-5626-0

    authors: Jin M,Hu Y,Wu W,Luo Y,Tan Y,Yu J,Jin A,Yang L,Huang H,Wei G

    更新日期:2019-05-23 00:00:00

  • Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study.

    abstract:BACKGROUND:High-risk Human Papillomavirus (HPV) testing is replacing cytology in cervical cancer screening as it is more sensitive for preinvasive cervical lesions. However, the bottleneck of HPV testing is the many false positive test results (positive tests without cervical lesions). Here, we evaluated to what extent...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2518-4

    authors: Preisler S,Rebolj M,Ejegod DM,Lynge E,Rygaard C,Bonde J

    更新日期:2016-07-20 00:00:00

  • Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis.

    abstract:BACKGROUND:Treatment of locally advanced non-small-cell lung cancer is based on a combined approach. To study the impact of trimodal therapy for stage III-N2 NSCLC a single centre retrospective evaluation focusing on survival and therapy-related toxicity was performed. METHODS:71 patients diagnosed between March 2001 ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-572

    authors: Askoxylakis V,Tanner J,Kappes J,Hoffmann H,Nicolay NH,Rief H,Debus J,Thomas M,Bischof M

    更新日期:2014-08-07 00:00:00

  • The oncogenic effects of HES1 on salivary adenoid cystic carcinoma cell growth and metastasis.

    abstract:BACKGROUND:Our previous study demonstrated a close relationship between NOTCH signaling pathway and salivary adenoid cystic carcinoma (SACC). HES1 is a well-known target gene of NOTCH signaling pathway. The purpose of the present study was to further explore the molecular mechanism of HES1 in SACC. METHODS:Comparative...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4350-5

    authors: Huang XY,Gan RH,Xie J,She L,Zhao Y,Ding LC,Su BH,Zheng DL,Lu YG

    更新日期:2018-04-17 00:00:00

  • Weight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France.

    abstract:BACKGROUND:Overweight and weight gain throughout adult life have been associated with increased risk of breast cancer after the menopause. However the role of body weight at a young age and of the timing of weight gain over the lifetime in postmenopausal breast cancer is not well documented. METHODS:We conducted a pop...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2793-0

    authors: Cordina-Duverger E,Truong T,Anger A,Sanchez M,Arveux P,Kerbrat P,Guénel P

    更新日期:2016-09-29 00:00:00

  • Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.

    abstract:BACKGROUND:New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O6-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression. Moreover, the presenc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-511

    authors: Oliver JA,Ortiz R,Melguizo C,Alvarez PJ,Gómez-Millán J,Prados J

    更新日期:2014-07-11 00:00:00

  • Can p503s, p504s and p510s gene expression in peripheral-blood be useful as a marker of prostatic cancer?

    abstract:BACKGROUND:The aim of the study was to investigate whether p503S, p504S and p510S gene expression in peripheral-blood be useful as a diagnostic or prognostic marker of prostatic cancer. METHODS:Circulating cells were identified by reverse transcription-polymerase chain reaction (RT-PCR) to detect p503S, p504S and p510...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-111

    authors: Cardillo MR,Gentile V,Ceccariello A,Giacomelli L,Messinetti S,Di Silverio F

    更新日期:2005-09-05 00:00:00

  • Correction to: A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.

    abstract::An amendment to this paper has been published and can be accessed via the original article. ...

    journal_title:BMC cancer

    pub_type: 已发布勘误

    doi:10.1186/s12885-020-07245-x

    authors: Al-Khayal K,Vaali-Mohammed MA,Elwatidy M,Traiki TB,Al-Obeed O,Azam M,Khan Z,Abdulla M,Ahmad R

    更新日期:2020-09-01 00:00:00

  • Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death in the world. N6-methyladenosine (m6A) RNA methylation is dynamically regulated by m6A RNA methylation modulators ("writer," "eraser," and "reader" proteins), which are associated with cancer occurrence and development. Th...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6638-5

    authors: Qu N,Qin S,Zhang X,Bo X,Liu Z,Tan C,Wen G,Jiang H

    更新日期:2020-02-28 00:00:00

  • BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol.

    abstract:BACKGROUND:Prospective trials have demonstrated the advantage of dose-escalated radiotherapy for the biochemical and clinical control of intermediate risk prostate cancer. Dose escalation improves outcomes but increases risks of urinary and bowel toxicity. Recently the contribution of "spacers" positioned in the septum...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4492-5

    authors: Pasquier D,Bogart E,Bonodeau F,Lacornerie T,Lartigau E,Latorzeff I

    更新日期:2018-05-16 00:00:00

  • IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.

    abstract:BACKGROUND:Metastatic breast cancer carries a poor prognosis despite the success of newly targeted therapies. Treatment options remain especially limited for the subtype of triple negative breast cancer (TNBC). Several signaling pathways, including NF-κB, are altered in TNBC, and the complexity of this disease implies ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4507-2

    authors: House CD,Grajales V,Ozaki M,Jordan E,Wubneh H,Kimble DC,James JM,Kim MK,Annunziata CM

    更新日期:2018-05-25 00:00:00

  • Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.

    abstract:BACKGROUND:Standard chemotherapy in unresectable biliary tract carcinoma (BTC) patients is based on gemcitabine combined with platinum derivatives. However, primary or acquired resistance is inevitable and no second-line chemotherapy is demonstrated to be effective. Thus, there is an urgent need to identify new alterna...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-918

    authors: Peraldo-Neia C,Cavalloni G,Soster M,Gammaitoni L,Marchiò S,Sassi F,Trusolino L,Bertotti A,Medico E,Capussotti L,Aglietta M,Leone F

    更新日期:2014-12-05 00:00:00

  • Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis.

    abstract:BACKGROUND:This meta-analysis was performed to explore the impact of minimal residual disease (MRD) prior to transplantation on the prognosis for patients with acute lymphoblastic leukemia (ALL). METHODS:A systematic search of PubMed, Embase, and the Cochrane Library was conducted for relevant studies from database in...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-018-4670-5

    authors: Shen Z,Gu X,Mao W,Yin L,Yang L,Zhang Z,Liu K,Wang L,Huang Y

    更新日期:2018-07-23 00:00:00

  • Novel transcripts from a distinct promoter that encode the full-length AKT1 in human breast cancer cells.

    abstract:BACKGROUND:The serine-threonine kinase AKT1 plays essential roles during normal mammary gland development as well as the initiation and progression of breast cancer. AKT1 is generally considered a ubiquitously expressed gene, and its persistent activation is transcriptionally controlled by regulatory elements character...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-195

    authors: Schmidt JW,Wehde BL,Sakamoto K,Triplett AA,West WW,Wagner KU

    更新日期:2014-03-15 00:00:00

  • Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.

    abstract:BACKGROUND:Circular RNAs (circRNAs) have emerged as a novel category of non-coding RNA, which exhibit a pivotal effect on regulating gene expression and biological functions, yet how circRNAs function in osteosarcoma (OSA) still demands further investigation. This study aimed at probing into the function of hsa_circ_00...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07515-8

    authors: Li H,He L,Tuo Y,Huang Y,Qian B

    更新日期:2020-10-23 00:00:00

  • The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.

    abstract:BACKGROUND:Malignant Pleural Mesothelioma (MPM) is an aggressive tumor arising from mesothelial cells lining the pleural cavities characterized by resistance to standard therapies. Most of the molecular steps responsible for pleural transformation remain unclear; however, several growth factor signaling cascades are kn...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1363-1

    authors: Pignochino Y,Dell'Aglio C,Inghilleri S,Zorzetto M,Basiricò M,Capozzi F,Canta M,Piloni D,Cemmi F,Sangiolo D,Gammaitoni L,Soster M,Marchiò S,Pozzi E,Morbini P,Luisetti M,Aglietta M,Grignani G,Stella GM

    更新日期:2015-05-08 00:00:00

  • AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003.

    abstract:BACKGROUND:Primary central nervous system lymphoma (PCNSL) is a frequent complication in acquired immunodeficiency syndrome (AIDS). The objective of this survey was to investigate incidence, clinical features, radiological findings, histologic diagnosis, treatment and outcome for all patients with histologically verifi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-225

    authors: Haldorsen IS,Kråkenes J,Goplen AK,Dunlop O,Mella O,Espeland A

    更新日期:2008-08-06 00:00:00

  • Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes.

    abstract:BACKGROUND:Colorectal-cancer is a leading cause of cancer death in the United States, and Latinos have particularly low rates of screening. Strategies and Opportunities to STOP Colon Cancer in Priority Populations (STOP CRC) is a partnership among two research institutions and a network of safety net clinics to promote...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1186/1471-2407-14-55

    authors: Coronado GD,Vollmer WM,Petrik A,Aguirre J,Kapka T,Devoe J,Puro J,Miers T,Lembach J,Turner A,Sanchez J,Retecki S,Nelson C,Green B

    更新日期:2014-02-26 00:00:00

  • Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapy.

    abstract:BACKGROUND:Li-Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome that is commonly associated with a germline mutation in the tumor suppressor gene p53. Loss of p53 results in increased expression of CD44, a cancer stem cell (CSC) marker, which is involved in the scavenging of reactive oxygen species...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-444

    authors: Yoshida GJ,Fuchimoto Y,Osumi T,Shimada H,Hosaka S,Morioka H,Mukai M,Masugi Y,Sakamoto M,Kuroda T

    更新日期:2012-10-02 00:00:00

  • Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma.

    abstract:BACKGROUND:Early diagnosis is important for the timely treatment of gallbladder carcinoma (GBC) patients and may lead to increased survival outcomes. Here, we have applied serological proteome analysis (SERPA), an immunoproteomics approach, for the detection of 'tumor-associated antigens (TAAs) that elicit humoral resp...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07676-6

    authors: Akhtar J,Priya R,Jain V,Sakhuja P,Agarwal AK,Goyal S,Polisetty RV,Sirdeshmukh R,Kar S,Gautam P

    更新日期:2020-12-01 00:00:00

  • A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer.

    abstract:BACKGROUND:Cell-free DNA's (cfDNA) use as a biomarker in cancer is challenging due to genetic heterogeneity of malignancies and rarity of tumor-derived molecules. Here we describe and demonstrate a novel machine-learning guided panel design strategy for improving the detection of tumor variants in cfDNA. Using this app...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07318-x

    authors: Cario CL,Chen E,Leong L,Emami NC,Lopez K,Tenggara I,Simko JP,Friedlander TW,Li PS,Paris PL,Carroll PR,Witte JS

    更新日期:2020-08-28 00:00:00